Allergic Conjunctivitis Market is an inflammation of the eyes caused by an allergic reaction to allergens such as pollen, mold spores, dust mites, and animal fur. It is the body's response to substances that have the potential to cause harm. The conjunctiva, a membrane that lines the inside of the eyeball, is sensitive to allergens. Red, itchy, watery, and burning eyes are some of the symptoms of allergic conjunctivitis. Oral medicines, eye drops, and immunotherapy are all options for treating allergic conjunctivitis.
During the forecast period, the market is expected to develop due to an increase in the frequency and incidence of allergic conjunctivitis.
Over the forecast period, the worldwide Allergic Conjunctivitis Market is expected to develop due to an increase in the incidence and prevalence of allergic conjunctivitis. In India, for example, according to Clinical Epidemiology and Global Health, the prevalence of allergic conjunctivitis was 12.22% in 2019, with allergic conjunctivitis being recorded in more males (13.44%) than females (10.71%).
During the projected period, key businesses concentrating on allergic conjunctivitis research & development are expected to fuel market expansion.
The development of treatments for allergic conjunctivitis is likely to boost the worldwide allergic conjunctivitis market growth over the forecast period, according to key players in the industry. For example, Ocular Therapeutix, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced topline results from its Phase 3 clinical trial to assess the safety and efficacy of DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis in April 2020. (AC).
The Impact of Coronavirus on the Global Allergic Conjunctivitis Market (COVID-19) Pandemic
The COVID-19 virus has spread to over 100 nations since its outbreak in December 2019, prompting the World Health Organization to designate it as a public health emergency. According to a World Health Organization estimate, coronavirus (COVID-19) has infected over 198 million people worldwide as of August 2, 2021.
Players to Watch
Eton Pharmaceutical, Sun Pharmaceutical Industries Ltd., Novartis AG., Bausch & Lomb Incorporated., Allergan, Ocular Therapeutix, Inc., Eyevance Pharmaceuticals LLC, Alcon, Santen Pharmaceutical Co., Ltd., Leuven Therapeutics, and Atopix Therapeutics Ltd. are major players in the global allergic conjunctivitis market.
Source Link:https://bit.ly/3dSevCj
0 Comments